About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials in Houston | 163 Studies

Clinical Trials COVID-19Houston

COVID-19 Clinical Trials in Houston

Find 163 clinical trials for covid-19 near Houston, Texas. Connect with research centers in your area.

All COVID-19 trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 163 trials

CompletedA Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine BoostersThe main goal of Part A of this study is to assess the safety, reactogenicity, and immunogenicity of the study vaccine candidates.NCT05137236·Phoenix, Arizona and 16 others CompletedA Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years OldThe primary goal of this study is to evaluate the safety and reactogenicity of multi-component vaccines mRNA-1045 (Influenza and RSV) and mRNA-1230 (influenza, RSV, and…NCT05585632·DeLand, Florida and 29 others

COVID-19 Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedTafenoquine in Patients With Mild to Moderate COVID-19A clinical study to assess the efficacy and safety of oral tafenoquine compared to placebo in patients with mild to moderate COVID 19 disease.NCT04533347·Miami, Florida and 9 others

CompletedACTIV-3: Therapeutics for Inpatients With COVID-19This study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection.NCT04501978·Tucson, Arizona and 134 others

CompletedA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19The main aim of this study is to evaluate the efficacy of S-217622 versus placebo among outpatient adults with mild and moderate COVID-19 starting intervention within 3 days of…NCT05305547·Guntersville, Alabama and 195 others

CompletedPhase 3 Adolescent Study for SARS-CoV-2 rS Variant VaccinesThis study is a large-scale investigation (Phase 3) into a new booster shot designed specifically for teenagers.NCT05973006·Davie, Florida and 19 others

CompletedThe Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2Subjects who have documented exposure to SARS-CoV-2 (COVID-19) will receive 4 doses of PUL-042 Inhalation Solution or 4 doses of a placebo solution by inhalation over 10 days.NCT04313023·Orange, California and 14 others

CompletedA Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease resulting from Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) infection.NCT04470427·Birmingham, Alabama and 99 others

CompletedA Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of AgeThis study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concerns (VOCs) in…NCT05436834·Bessemer, Alabama and 73 others

CompletedTranscutaneous Electrical Nerve Stimulation (TENS) in Patients With Postacute Sequelae of Sars-CoV-2The purpose of the pilot study is to examine acceptability and proof of concept effectiveness of a wireless TENS technology to address PASC associated FM.NCT05200858·Houston, Texas

TerminatedA Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pulsed inhaled iNO compared to placebo in subjects with COVID-19.NCT04421508·Phoenix, Arizona and 16 others

CompletedA Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy ChildrenThe purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called variant-adapted BNT162b2 RNA-based…NCT05543616·Birmingham, Alabama and 95 others

TerminatedNasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)The purpose of this study is to evaluate the safety and effectiveness of NasoVAX in preventing worsening of symptoms and hospitalization in patients with early COVID-19.NCT04442230·Miami, Florida and 6 others

CompletedA Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy ParticipantsThis is a Phase 3, randomized, observer-blind study in healthy individuals.NCT04713553·Oakland, California and 16 others

CompletedA Study of Modified mRNA Vaccines in Healthy AdultsThe main goal of this study is to evaluate the safety, reactogenicity, and immunogenicity of study vaccines.NCT05397223·Hollywood, Florida and 7 others

CompletedTrial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 InfectionTrial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare…NCT04359680·Hot Springs, Arkansas and 25 others

CompletedCyclosporine For The Treatment Of COVID-19(+)Phase IIa clinical trial in which 75 non-ICU hospital inpatients will be randomized 2:1 to 7 days of an oral formulation of cyclosporine, Neoral (2.5mg/kg PO BID) + standard of…NCT04492891·Houston, Texas

CompletedCOVID Protection After Transplant-Immunosuppression ReductionThis study will enroll individuals who have: * Completed primary series of mRNA COVID-19 vaccine, and * An antibody response ≤ 2500 U/mL measured at least 30 days after the last…NCT05077254·San Diego, California and 14 others

CompletedThe Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 InfectionAdults who have tested positive for SARS-CoV-2 infection and who may require supplemental oxygen will receive PUL-042 Inhalation Solution or placebo 3 times over a one week period…NCT04312997·Orange, California and 10 others

RecruitingA Study of COVID-19 Vaccine(s) in Children and AdultsThe purpose of this study is to learn about the safety and effects of updated COVID-19 vaccines (called BNT162b2) in participants 5 Through 64 Years of Age with risk factors for…NCT07798648·Homestead, Florida and 13 others

PreviousPage 4 of 9Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia